Hostname: page-component-84b7d79bbc-dwq4g Total loading time: 0 Render date: 2024-07-25T16:51:47.106Z Has data issue: false hasContentIssue false
  • English
  • Français

The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972–1987

Published online by Cambridge University Press:  19 October 2009

M. Karvonen ,
J. Tuomilehto ,
J. Pitkäniemi  and
P. Saikku
M. Karvonen
Affiliation:
Department of Epidemiology, National Public Health Institute, Elimäenkatu 25, SF-00510 Helsinki, Finland Department of Bacteriology, National Public Health Institute, Helsinki, Finland
J. Tuomilehto
Affiliation:
Department of Epidemiology, National Public Health Institute, Elimäenkatu 25, SF-00510 Helsinki, Finland
J. Pitkäniemi
Affiliation:
Department of Epidemiology, National Public Health Institute, Elimäenkatu 25, SF-00510 Helsinki, Finland
P. Saikku
Affiliation:
Department of Virology, University of Helsinki, Helsinki, Finland
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The epidemic cycle of Chlamydia pneumoniae infection was examined in two areas in eastern Finland over a period of 15 years, 1972–87. The C. pneumoniae IgG antibody prevalence was determined with 5-year intervals in a random sample of the population aged 25–59 years. The total number of sera studied using immunofluorescence was 2387. In 1972 the antibody prevalence was 57% and it increased to 66% in 1977. Over the next 5 years the prevalence decreased to 44% in 1982, but by 1987 it had again increased to 59%. The temporal variation in prevalence was statistically significant (P < 0·001) and similar for both genders. Throughout the observation period the overall prevalence Mas 7–11% higher in men than in women (P < 0·01). The antibody prevalence increased with age, being the highest among the oldest study subjects of both genders. The periods of high and low prevalence alternated in an epidemic cycle (P < 0·001) of about 10 years

Type
Research Article
Information
Epidemiology & Infection , Volume 110 , Issue 2 , April 1993 , pp. 349 - 360
Copyright
Copyright © Cambridge University Press 1993

References

REFERENCES

1.Karvonen, M, Tuomilehto, J, Naukkarinen, A, Saikku, P. The prevalence and regional distribution of antibodies against Chlamydia penumoniae (Strain TWAR) in Finland in 1958. Int J Epidemiol 1992; 21: 391–8.CrossRefGoogle Scholar
2.Saikku, P, Sp, Wang, Kleemola, M, Brander, E, Rusanen, E, Jt, Grayston. An epidemic of mild pneumonia due to an unusual Chlamydia psittaci strain. J Infect Dis 1985; 151: 832–9.CrossRefGoogle Scholar
3.Kleemola, M, Saikku, P, Visakorpi, R, Sp, Wang, Jt, Grayston. Epidemics of pneumoniae caused by TWAR, a new Chlamydia organism, in military trainees in Finland. J Infect Dis 1988; 157: 230–6.CrossRefGoogle ScholarPubMed
4.Mr, Ekman, Saikku, P, Kleemola, M, Visakorpi, R, CC, Kuo, Jt, Grayston. Mild asymptomatic respiratory infection with Chlamydia TWAR during a military pneumonia epidemic. In Proceedings of the First Conference of the European Society for Chlamydia Research. Bologna: Societa Editrice Esculapio, 1988: 56.Google Scholar
5.Jt, Grayston, Mordhorst, C, Al, Bruu, Vene, S, Sp, Wang. Countrywide epidemics of Chlamydia pneumoniae strain TWAR. in Scandinavia, 1981–1983. J Infect Dis 1989: 159. 1111–14.Google Scholar
6.Ch, Mordhorst, Sp, Wang, Myhra, W, Jt, Grayston. Chlamydia pneumoniae, strain TWAR. infections in Denmark 1975–1987. In: Wr, Bowie et al. eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 418–21.Google Scholar
7.Saikku, P, Leinonen, M, Mattila, K et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute mvocardial infarction. Lancet 1988; ii: 983–6.CrossRefGoogle Scholar
8.Saikku, P, Leiononen, M, Tenkanen, L, Manninen, V, Jk, Huttunen. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease (CHD) in the Helsinki Heart Study (HHS). Ann Int Med 1992; 116: 273–8.CrossRefGoogle Scholar
9.Dh, Thorn, Sp, Wang, Jt, Grayston et al. Chlamydia pneumoniae Strain TWAR antibody and angiographically demonstrated coronary artery disease. Arterioscler Thromb 1991; 11: 547–51.Google Scholar
10.Dh, Thorn, Jt, Grayston. Ds, Siscovick. Sp, Wang, Ns, Weiss. Jr, Daling. Association of prior infection with Chlamydia pneumoniae and angiographicallv demonstrated coronary artery disease. JAMA 1992; 268: 68–72.Google Scholar
11.Pisa, Z, Uemura, K. International differences in developing improvements in cardiovascular health. Ann Med 1989; 21: 193–7.CrossRefGoogle ScholarPubMed
12.Tuomilehto, J, Puska, P, Korhonen, H et al. Trends and determinants of ischaemie heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s. Int J Epidemiol 1989; 18 (Suppl. 1): S109–S117.CrossRefGoogle Scholar
13.Vartiainen, E, Korhonen, H, Pietinen, P et al. Fifteen-year trends in coronary risk factors in Finland, with special reference to North Karelia. Int J Epidemiol 1991: 20: 651–61.CrossRefGoogle ScholarPubMed
14.Tuomilehto, J, Geboers, J, Salonen, J, Nissinen, A. Kuulasmaa, K. Puska, P. Decline in cardiovascular mortality in North Karelia and in other parts of Finland. Br Med J 1986: 293: 1068–71.CrossRefGoogle ScholarPubMed
15.Puska, P, Tuomilehto, J, Salonen, J et al. . Community control of cardiovascular diseases, the North Karelia project: evaluation of a comprehensive program for control of cardiovascular diseases in 1972–77 in North Karelia. Copenhagen: World Health Organisation/EURO. 1981: 69–71.Google Scholar
16.Sp, Wang, Jt, Grayston. Population prevalence antibody to Chlamydia pneumoniae. strain TWAR. In: Wr, Bowie et al. eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 403–5.Google Scholar
17.Statistical yearbook of Finland 1984. Helsinki: Central Statistical Office. 1985.Google Scholar
18.Goodall, B. Dictionary of human geography. Bungay. Suffolk: Chaucer Press Ltd. 1987: 487–8.Google Scholar
19.MeCullagh, P.Ja., NelderGeneralized linear models. London: Chapman and Hall. 1983.CrossRefGoogle Scholar
20.Bj, Winer. Statistical principles in experimental design. New York: McGraw-Hill Inc. 1971.Google Scholar
21.Sp, Wang, Jt, Grayston. Microimmunofluorescence serological studies with the TWAR organism. In: JD, Oriel et al. , eds. Chlamydial infections. Cambridge: Cambridge University Press, 1986: 329–32.Google Scholar
22.Vl, Popov, Aa, Shntkin, Vn, Pankratova et al. Ultrastructure of C. pbeumoniae in cell culture. FEMS Microbiol Letters 1991; 84: 129–34.Google Scholar
23.Dh, Thom, Jt, Grayston, Sp, Wang, CC, Kuo, Altinan, J. Chlamydia pneumoniae strain TWAII, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population. Am J Epidemiol 1990; 132: 248–56.Google Scholar
24.Jt, Grayston. Chlamydia pneumoniae, strain TWAR, a new important pathogen. In: Vaheri, et al. eds. Rapid methods and automation in microbiology and immunology. Berlin Heidelberg: Springer-Verlag, 1991: 284–56.Google Scholar
25.Patnode, D, Sp, Wang, Jt, Grayston. Persistence of Chlamydia pneumoniae, strain TWAR micro-immunofluorescent antibody. In: Wr, Howie et al. eds. Chlamydial infections. Cambridge: Cambridge University Press, 1990: 406–9.Google Scholar
26.Jt, Grayston, Sp, Wang, CC, Kuo, La, Campbell. Current knowledge of Chlamydia pneumoniae, strain TWAR, an important cause of pneumoniae and other acute respiratory disease. Eur J Clin Microbiol Infect Dis 1989; 8: 191–202.Google Scholar
27.Fryden, A, Kihlström, E, Maller, R et al. Clinical and epidemiological study of ‘Ornithosis’ caused by Chlamydia psitlaci and Chlamydia pneumoniae (strain TWAR). Scand J Infeet Dis 1989; 21: 681–91.CrossRefGoogle ScholarPubMed